Laboratory indices in clofibrate therapy of juvenile-onset diabetes.
D000293:Adolescent; D000328:Adult; D000738:Androsterone / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001777:Blood Coagulation; D001798:Blood Proteins / Q000032:analysis; D002087:Butyrates / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004798:Enzymes / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D001798:Blood Proteins; D002087:Butyrates; D004798:Enzymes; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D000738:Androsterone